SEARCH

SEARCH BY CITATION

References

  • 1
    Alter MJ. Epidemiology of hepatitis C. Hepatology 1997; 26 (suppl): 62S65S.
  • 2
    Min AD, Saxena R, Thung SN, Atillasoy EO, Wolf DC, Sauter B, et al. Outcome of hepatitis C patients with and without hepatocellular carcinoma undergoing liver transplant. Am J Gastroenterol 1998; 93: 21482153.
    Direct Link:
  • 3
    Ghobrial RM, Farmer DG, Baqurizo A, Colquhoun S, Rosen HR, Yersiz H, et al. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience. Ann Surg 1999; 229: 824831.
  • 4
    Boker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997; 25: 203210.
  • 5
    Casavilla FA, Rekela J, Kapur S, Irish W, McMichael J, Demetris AJ, et al. Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. Liver Transpl Surg 1998; 4: 448454.
  • 6
    Gane EP, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815820.
  • 7
    Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991; 214: 221228.
  • 8
    Farmer DG, Rosove MH, Shaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994; 219: 236247.
  • 9
    Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liv Dis 1999; 19: 311322.
  • 10
    Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 1998; 228: 479490.
  • 11
    Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991; 110: 726734.
  • 12
    Yokoyama I, Todo S, Iwatsuki S, Starzl TE. Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 1990; 37: 188193.
  • 13
    O'Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1988; 207: 373379.
  • 14
    Ringe B, Pichlmayi R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15: 270285.
  • 15
    Matsunami H, Shimizu Y, Lynch SV, Balderson GA, Ando Y, Strong RW. Liver transplantation as a therapeutic option for hepatocellular carcinoma. Oncology 2002; 62 (suppl 1): 8286.
  • 16
    Bosch FX, Munoz N. Hepatocellular carcinoma in the world: Epidemiologic questions. In: Tabor E., DiBisceglie AM., and Purcell RH. Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. Houston, TX: Gulf, 1991: 35. Advances in Applied Technology Series; Vol. 13.
  • 17
    Kiyosawa K, Tanaka E. Characteristics of hepatocellular carcinoma in Japan. Oncology 2002; 62 (suppl 1): 57.
  • 18
    Chung SW, Toth JL, Rezieg M, Cameron R, Taylor BR, Greig PD, et al. Liver transplantation for hepatocellular carcinoma. Am J Surg 1994; 167: 317321.
  • 19
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol 1997; 92: 14531457.
  • 20
    American Joint Committee on Cancer. Liver (including intrahepatic bile ducts). In: Bears O, Henason D, Hutter R, et al. Manual for Staging of Cancer. Philadelphia: Lippincott, 1992: 89.
  • 21
    Busuttil RW, Colonna JO II, Hiatt JR, Brems JJ, el Khoury G, Goldstein LI, et al. The first 100 liver transplantation at UCLA. Ann Surg 1987; 206: 387402.
  • 22
    Busuttil RW, Shaked A, Millis JM, Jurim O, Colquhoun SD, Shackleton CR, et al. One thousand liver transplants. The lessons learned. Ann Surg 1994; 219: 490497.
  • 23
    Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359362.
  • 24
    Gilliam JH III, Geinsinger KR, Richter JE. Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis. Ann Intern Med 1984; 101: 794795.
  • 25
    Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H, et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67: 429433.
  • 26
    Levero M, Tagger A, Balsano C, De Marzio E, Avantaggiati ML, Natoli G, et al. Antibodies to hepatitis C virus in patients with hepatocellular carcinoma. J Hepatol 1991; 12: 6063.
  • 27
    Takenaka K, Yamamoto K, Taketomi A, Itasaka H, Adachi E, Shirabe K, et al. A comparison of the surgical results in patients with hepatitis B- versus hepatitis C-related hepatocellular carcinoma. Hepatology 1995; 22: 2024.
  • 28
    Simonetti RG, Camma C, Fiorrello F, Cottone M, Rapicetta M, Marino L, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 1992; 116: 97102.
  • 29
    Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 218: 145151.
  • 30
    Bechstein WO, Blumhardt G, Lobeck H, Keck H, Lemmens HP, Knoop M, Neuhaus P. Selection of small hepatocellular carcinoma improves long-term results of hepatic transplantation for malignancy. Transpl Int 1994; (7 suppl 1): S238S240.
  • 31
    Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U, Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma. A retrospective analysis. Ann Surg 1998; 227: 424432.
  • 32
    Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 1996; 334: 693699.
  • 33
    Mc Peake JR, O'Grady JG, Zaman S, Portmann B, Wight DG, Tan KC, et al. Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol 1993; 18: 226234.
  • 34
    Michel J, Suc B, Fourtanier G, Durand D, Rumeau JL, Rostaing L, Lloveras JJ. Recurrence of hepatocellular carcinoma in cirrhotic patients after liver resection or transplantation. Transplant Proc 1995; 27: 17981800.
  • 35
    Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229: 790799.
  • 36
    Ojogho ON, So SK, Keeffe EB, Berquist W, Concepcion W, Garcia-Kennedy R, et al. Orthotopic liver transplantation for hepatocellular carcinoma. Factors affecting long-term patient survival. Arch Surg 1996; 131: 935939.
  • 37
    Molmenti EP, Marsh JW, Dvorchik I, Oliver JH, Madariaga J, Iwatsuki S. Hepatobiliary malignancies. Primary hepatic malignant neoplasms. Surg Clin North Am 1999; 79: 4357.
  • 38
    Iwatsuki S, Dvorchik I, Marsh JW, Madariaga JR, Carr B, Fung JJ, Starzl TE. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 2000; 191: 389394.
  • 39
    Stone MJ, Klintmalm GB, Polter D, Husberg BS, Mennel RG, Ramsay MA, et al. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology 1993; 104: 196202.
  • 40
    Cherqui D, Piedbois P, Pierga JY, Duvoux C, Vavasseur D, Tran Van-Nhieu J, et al. Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot study. Cancer 1994; 73: 27212726.
  • 41
    Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzl TE. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991; 68: 20952100.
  • 42
    Allison D, Jordan H, Hennessy O. Therapeutic embolization of the hepatic artery: a review of 75 procedures. Lancet 1985; 1: 595599.
  • 43
    Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, Roche A. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992; 163: 387394.
  • 44
    Olthoff KM, Rosove MH, Shackelton CR, Imagawa DK, Farmer DG, Northcross P, et al. Adjuvant chemotherapy improves survival after liver transplantation. Ann Surg 1995; 221: 734741.
  • 45
    Anselmo DM, Ghobrial RM, Jung LC, Weaver M, Cao C, Saab S, et al. New era of liver transplantation for hepatitis B. A 17-year single-center experience. Ann Surg 2002; 235: 611619.
  • 46
    Yao Y, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma. Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002; 8: 765774.
  • 47
    Yao Y, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 13941403.